Trial intelligence / Profile preview

Lidocaine vs Dexmedetomidine for Postoperative Delirium in Elderly

NCT07108764Recruiting

Sponsor
Tanta University
Start
Apr 2025
Primary completion
Apr 2027
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in postoperative delirium (POD) comparing Lidocaine group with Dexmedetomidine group (2 arms). Primary endpoint: Incidence of postoperative delirium at 3 days. Started Apr 2025; status: recruiting.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrinedexmedetomidine
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on NCT07108764.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07108764.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call